Literature DB >> 18097749

Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women.

Deepa B Patil1, Heather A Lankes, Ritu Nayar, Shahla Masood, Michelle Bryk, Nanjiang Hou, Alfred Rademaker, Seema A Khan.   

Abstract

BACKGROUND: Ductal lavage (DL) allows repeat sampling of breast epithelium for serial observation in a chemoprevention setting; however, the reproducibility of duct cannulation, cell yield and cytology has not been addressed.
METHODS: We conducted a Phase 2 trial, wherein high risk women chose tamoxifen treatment or observation following an entry DL procedure. We present data from the non-intervention arm of our study to assess the reproducibility of cannulation, cell yield, and cytologic diagnosis from DL of the same duct at two time-points. Inter-observer variability was assessed by a blinded review of Papanicoloau-stained slides by two cytopathologists.
RESULTS: Sixty-five women had a successful lavage of 187 ducts at baseline and chose observation; 63/65 (97%) had a successful lavage 6 months later. Successful recannulation of the same duct was accomplished in 63 women (97%) and162 ducts (87%). Total epithelial cell yields >or=100 were obtained from 57/65 women (88%) and 129/187 ducts (69%) at baseline, and 46/63 women (73%) and 80/162 ducts (49%) at both time-points. Cytologic diagnosis was reproducible in 27/63 (43%) women and 77/162 (48%) ducts. Inter-observer variability for cytologic diagnosis between two observers showed good agreement (kappa = 0.62).
CONCLUSIONS: Recannulation and lavage of the same duct after a 6 month interval can be achieved with high frequency; however, reproducibility of cell yield and cytologic findings from the same duct is sub-optimal, leading to significant attrition of evaluable subjects. The utility of DL for the serial monitoring of breast epithelium is therefore limited.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18097749     DOI: 10.1007/s10549-007-9861-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  10 in total

1.  Correlation of ductal lavage cytology with ductoscopy-directed duct excision histology in women at high risk for developing breast cancer: a prospective, single-institution trial.

Authors:  Amy E Cyr; Julie A Margenthaler; Jill Conway; Antonella L Rastelli; Rosa M Davila; Feng Gao; Jill R Dietz
Journal:  Ann Surg Oncol       Date:  2011-08-17       Impact factor: 5.344

2.  Status of Intraductal Therapy for Ductal Carcinoma in Situ.

Authors:  Meghan Flanagan; Susan Love; E Shelley Hwang
Journal:  Curr Breast Cancer Rep       Date:  2010-05-06

3.  Obesity is associated with atypia in breast ductal lavage of women with proliferative breast disease.

Authors:  Zora Djuric; Ann Edwards; Shashi Madan; Linda Darga; Jianwei Ren; Cassann Blake; Mathew Koletsky; Lance K Heilbrun
Journal:  Cancer Epidemiol       Date:  2009-07-28       Impact factor: 2.984

4.  Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?

Authors:  Jennifer T Loud; Anne C M Thiébaut; Andrea D Abati; Armando C Filie; Kathryn Nichols; David Danforth; Ruthann Giusti; Sheila A Prindiville; Mark H Greene
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

5.  Does ductal lavage assert its role as a noninvasive diagnostic modality to identify women at low risk of breast cancer development?

Authors:  Ioanna Konstandiadou; Aikaterini Mastoraki; Olympia Kotsilianou; Petros Karakitsos; George Athanasas; Vasilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  J Gynecol Oncol       Date:  2012-04-03       Impact factor: 4.401

6.  Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer.

Authors:  Takahiro Yoshida; Kideok Jin; Hong Song; Sunju Park; David L Huso; Zhe Zhang; Han Liangfeng; Charles Zhu; Frank Bruchertseifer; Alfred Morgenstern; George Sgouros; Saraswati Sukumar
Journal:  Oncotarget       Date:  2016-05-31

7.  Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer.

Authors:  Jennifer T Loud; Ellen Burke Beckjord; Kathryn Nichols; June Peters; Ruthann Giusti; Mark H Greene
Journal:  BMC Womens Health       Date:  2009-07-14       Impact factor: 2.809

8.  Comparison of Random Periareolar Fine Needle Aspirate versus Ductal Lavage for Risk Assessment and Prevention of Breast Cancer.

Authors:  Abigail Hoffman; Rod Pellenberg; Catherine Ibarra Drendall; Victoria Seewaldt
Journal:  Curr Breast Cancer Rep       Date:  2012-06-22

9.  Characteristics of Breast Ducts in Normal-Risk and High-risk Women and Their Relationship to Ductal Cytologic Atypia.

Authors:  David N Danforth; Armando C Filie; Andrew C Warner; George W Wright; Zhonghe Sun; Thomas Ried; Christine T McGowan; Sheila A Prindiville
Journal:  Cancer Prev Res (Phila)       Date:  2020-08-04

10.  Examination of Duct Physiology in the Human Mammary Gland.

Authors:  Dixie Mills; Ameer Gomberawalla; Eva J Gordon; Julie Tondre; Mitra Nejad; Tinh Nguyen; Janice M Pogoda; Jianyu Rao; Robert Chatterton; Susanne Henning; Susan M Love
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.